List of Excipients in API insulin glargine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing insulin glargine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | GLYCERIN | |
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | HYDROCHLORIC ACID | |
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | METACRESOL | |
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | POLYSORBATE 20 | |
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | SODIUM HYDROXIDE | |
| A-S Medication Solutions | LANTUS | insulin glargine | 50090-0876 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for insulin glargine
Excipient focus: GLYCERIN
insulin glargine drug variants containing GLYCERIN
insulin glargine drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
insulin glargine drug variants containing HYDROCHLORIC ACID
insulin glargine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| A-S Medication Solutions | insulin glargine | 50090-2193 |
| A-S Medication Solutions | insulin glargine | 50090-4177 |
| >Company | >Ingredient | >NDC |
Excipient focus: METACRESOL
insulin glargine drug variants containing METACRESOL
insulin glargine drug variants not containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
insulin glargine drug variants containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | insulin glargine and lixisenatide | 0024-5761 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing METHIONINE
Excipient focus: POLYSORBATE 20
insulin glargine drug variants containing POLYSORBATE 20
insulin glargine drug variants not containing POLYSORBATE 20
Excipient focus: SODIUM HYDROXIDE
insulin glargine drug variants containing SODIUM HYDROXIDE
insulin glargine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | insulin glargine | 0024-5869 |
| A-S Medication Solutions | insulin glargine | 50090-2193 |
| A-S Medication Solutions | insulin glargine | 50090-4177 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
insulin glargine drug variants containing WATER
insulin glargine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC
insulin glargine drug variants containing ZINC
insulin glargine drug variants not containing ZINC
Excipient focus: ZINC CHLORIDE
insulin glargine drug variants containing ZINC CHLORIDE
insulin glargine drug variants not containing ZINC CHLORIDE
Excipient focus: ZINC OXIDE
insulin glargine drug variants containing ZINC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin glargine | 0002-7715 |
| >Company | >Ingredient | >NDC |
insulin glargine drug variants not containing ZINC OXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
